Dofinansowanie ze środków budżetu państwa
Deklaracja dostępności
Funding for the OMNIPLANT project We are pleased to announce that under the European Funds for Smart Economy Programme 2021–2027, Action 2.4 Research Infrastructure for a Modern Economy, the Institute of Bioorganic Chemistry of the Polish Academy of Sciences (project leader – Anna Wojakowska, PhD, DSc, Assoc. Prof.), acting as the consortium leader, has obtained funding for the project OMNIPLANT: Omics and Microscopy Network for Integrated PLANT cell analysis.
The members of the consortium are: the Institute of Bioorganic Chemistry (leader), Adam Mickiewicz University in Poznań, and the Institute of Plant Genetics of the Polish Academy of Sciences.
The business contribution is provided by Diag-Med Ltd.
The OMNIPLANT project was conceived in response to one of the most important and at the same time most complex challenges facing contemporary science, agriculture, forestry, and biotechnology – how to effectively and precisely understand the mechanisms governing plant functioning at the single-cell level in order to address the growing problems associated with global climate change, environmental degradation, loss of soil fertility, and declining biodiversity. These changes place increasing pressure on agriculture and forestry, which must not only improve productivity but also enhance plant resilience to biotic and abiotic stresses while minimizing negative impacts on ecosystems.
The main objective of the OMNIPLANT project is to establish in Poland a modern, interdisciplinary, and comprehensive research infrastructure dedicated to advanced imaging and multi-omics analysis of individual plant cells. This infrastructure will enable the integration of proteomics, metabolomics, and transcriptomics data, as well as imaging of structural and chemical composition at the subcellular level. As a result, it will be possible to generate a holistic picture of the molecular and physiological processes that determine plant functioning and adaptation. The project will establish laboratories offering a wide range of research and analytical services to the scientific community and businesses in the agrobiotechnology and forestry sectors.
OMNIPLANT will support both basic research, contributing to the advancement of knowledge on plant biology, and applied research focused on practical solutions, such as the development of new plant varieties resistant to drought, pathogens, or soil contamination, the development of environmentally friendly biopreparations and plant protection products, and the advancement of precision agriculture technologies.
The project will also foster cross-sectoral cooperation, bringing together academia, industry, the business community and society, and promote the transfer of knowledge and technology at both national and international levels.
The total value of the project is PLN 35,762,119.11, and the amount of funding from the European Funds for the entire consortium is PLN 24,306,091.20.
The project is co-funded by the European Union under the European Funds for Smart Economy Programme. #EUFunds #EuropeanFunds
Funding for the G4PL – Genomics for Poland project!
We are pleased to announce that the project entitled G4PL – Genomics for Poland, headed by Prof. Luiza Handschuh, has received funding from the European Funds for a Smart Economy (FENG) program, Action 2.4 Research Infrastructure of Modern Economy.
The consortium leader, the Institute of Bioorganic Chemistry PAS, including the Poznan Supercomputing and Networking Center, will collaborate with eleven research units:
• Institute of Human Genetics PAS
• Nencki Institute of Experimental Biology PAS
• Poznan University of Technology
• University of Warsaw
• Medical University of Bialystok
• University of Lodz
• University of Gdansk
• Jagiellonian University
• Cardinal Stefan Wyszynski National Institute of Cardiology – National Research Institute in Warsaw
• Maria Sklodowska-Curie National Research Institute of Oncology – Gliwice Branch
• Łukasiewicz Research Network – Polish Center for Technology Development.
The primary objective of the project is to establish a nationwide network of laboratories conducting research and providing services in the field of genomics, serving academic commercial and healthcare institutions. These activities will support the development of science, personalized medicine, precise diagnostics, innovative therapies, and targeted prevention.
The network will be equipped with advanced infrastructure for genome research, including high-throughput long-read sequencing machines and a device for creating optical maps. The project will also result in the collection of new genomes, including those from patients with rare diseases, the integration and re-analysis of existing data, and their sharing within a nationwide repository. New IT tools for genome analysis will also be developed, utilizing artificial intelligence algorithms and quantum technologies.
Population genomic research contributes to a deeper understanding of genetic variation, disease prevalence, and predisposition, enabling improved diagnostics, personalized treatment, and more effective preventive measures. It also translates into tangible economic benefits, as well-targeted prevention, precise diagnostics, and personalized therapy reduce healthcare costs. The project plans to sequence samples from 6,000-7,000 donors. Some of these samples will constitute Poland's contribution to the Genome of Europe (GoE) project.
Project value: PLN 248,337,770.24.
Project funding: PLN 180,481,656.59.
Implementation period: 2026-2029.
The non-financial contribution to the project is made by BCODERS S.A. and Analityk Genetyka Unrug Wójtowicz Sp. k.
The project is co-financed by the European Union under the European Funds for a Smart Economy program.
#EUFunds #EuropeanFunds
#FunduszeUE #FunduszeEuropejskie
Funding awarded to the POL-OPENSCREEN – Polish Platform of Screening Infrastructure for Biological Chemistry We are pleased to announce that, as part of action 2.4 Research Infrastructure for a Modern Economy (FENG), the research team consisting of: • Dorota Jakubczyk, PhD • Dorota Kwiatek, PhD • Miłosz Ruszkowski, PhD, DSc, Assoc. Prof. • Krzysztof Żukowski, PhD • Maria Małecka, PhD, Eng. has secured funding for the POL-OPENSCREEN – Polish Platform of Screening Infrastructure for Biological Chemistry. The project is the result of collaboration with the Institute of Medical Biology PAS (the consortium leader) and the Center for Molecular and Macromolecular Studies PAS. The following units of the IBCH PAS are involved in the project: the ERIC Center for Chemical Biology, including the Laboratory of Medicinal Chemistry (headed by Dorota Jakubczyk, PhD) and the Laboratory of Molecular Assays and Imaging (headed by Dorota Kwiatek, PhD), and the Department of Structural Biology of Eukaryotes (headed by Miłosz Ruszkowski, PhD, DSc, Assoc. Prof.). The aim of the project is to develop a unique-in-Poland and globally leading comprehensive infrastructure for the identification of molecular targets, screening, verification, and optimization of biologically active substances. The planned universal design of the platform will enable the discovery and development of substances with potential medical applications, particularly drugs, as well as chemical compounds and other substances for use in basic research (e.g., selective inhibitors) and in the agricultural, food, and cosmetic industries, in a high-throughput and efficient manner. The project tasks include the creation and development of a unique high-throughput research infrastructure in the field of "drug discovery." These activities will focus on the development and optimization of screening protocols, measurement of interactions between molecular targets and bioactive compounds selected as “HITs,” as well as the synthesis and biosynthesis of these bioactive compounds. The project includes the purchase and installation of equipment, the development of intangible assets and intellectual property related to laboratory protocols, and training for personnel. Additionally, promotional activities are planned to encourage users to take advantage of the newly established infrastructure. The target groups of the project include scientific institutions such as universities and institutes of the Polish Academy of Sciences, as well as companies engaged in research in the broadly defined field of drug design and development of other biologically active substances. The interdisciplinary nature of the project and the use of state-of-the-art equipment will attract both domestic and international research units and companies. Project value: PLN 34,698,325.61 Project funding: PLN 24,831,715.68 (including funding for ICHB PAN amounting to PLN 15,649,507.20). The project will be implemented between 2025 and 2027. The project is co-financed by the European Union under the European Funds for Smart Economy programme. #EUFunds #EuropeanFunds
Funding awarded to the ECBiG – MOSAIC 3D project We are pleased to announce that, as part of the European Funds for a Modern Economy 2021-2027 Programme (FENG), Action 2.4 Research Infrastructure for a Modern Economy the team consisting of: Prof. Marek Figlerowicz,Natalia Koralewska, PhDIreneusz Stolarek, PhDRobert Pękal, MSc, Eng. has secured funding for the ECBG project – European Center for Bioinformatics and Genomics – MOSAIC 3D. The aim of the project is to create a unique research infrastructure that enables the development of advanced 3D pre-clinical models (in vitro-3D) and their digital twins (in silico-3D), which will subsequently be used in translational research focused on oncological and cardiological diseases. The project includes the acquisition of research equipment for cell culture, live-cell analysis, and biobanking, as well as expanding the ECBG resources with unique cell lines derived from biological material obtained from patients with selected cardiological and oncological diseases. Additionally, a service platform will be developed to support the creation and use of digital twins of cell and tissue models in biomedical research. ECBG-MOSAIC 3D research infrastructure will integrate advanced technologies for 3D cell culturing, spatial analysis of gene expression at both the cellular and subcellular levels, and the creation of digital twins of biological systems using machine learning algorithms. The tools developed in this project will allow for multi-level modeling of the development of pathological states and therapy effects in live cells and their digital counterparts, opening new possibilities in biomedical research and supporting the development of personalized therapies. The users of the infrastructure developed in this project will include both national and international research institutions, healthcare units, and business entities from the biotechnology, pharmaceutical, and biomedical sectors. The total funding for the project amounts to PLN 52,746,351.03, including a grant amount of PLN 40,000,000. The project will be implemented from 2025 to 2028. Project co-financed by the European Union under the European Funds for Smart Economy programme. #EUFunds #EuropeanFunds
Accessibility Tools
